[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.247.205. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 20, 1993

Defining the Group A Streptococcal Toxic Shock SyndromeRationale and Consensus Definition

Author Affiliations

Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Ga; Bureau of Public Health, Wisconsin Division of Health, Madison; Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Ga; Department of Pediatrics, University of Alabama School of Medicine, Birmingham; Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Ga; Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio; Department of Microbiology, University of Minnesota, Minneapolis; Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Ga; Department of Medicine, Boise Veterans Administration Hospital, Boise, Idaho; Department of Pediatrics, University of Colorado School of Medicine, Denver
From The Working Group on Severe Streptococcal Infections.

JAMA. 1993;269(3):390-391. doi:10.1001/jama.1993.03500030088038
Abstract

GROUP A streptococcus (Streptococcus pyogenes) may cause a variety of illnesses ranging from very common, usually clinically mild conditions such as pharyngitis and impetigo to less common severe infections including septicemia and pneumonia. In 1987, Cone et al1 described two patients with severe group A streptococcal infections having clinical features similar to the staphylococcal toxic shock syndrome. This syndrome, designated the "streptococcal toxic shock—like syndrome" or the "toxic streptococcal syndrome,"2 was further characterized by Stevens et al3 in a series of 20 patients. Most patients included in this series were less than 50 years old and otherwise healthy. All had invasive group A streptococcal infections characterized by signs including shock, multi—organ system involvement, and rapidly progressive, destructive soft-tissue infection (necrotizing fasciitis). The case-fatality rate was 30% even though most patients received appropriate antimicrobial therapy, supportive care, and, where necessary, surgical débridement. Ten available isolates were serotyped and

×